Search
Now showing items 1-3 of 3
HIV/AIDS patients display lower relative bioavailability of Efavirenz than healthy subjects
(Adis Data Information BV., 2011)
Background: Pharmacokinetic studies of antiretroviral drugs are often conducted in adult healthy subjects, and the results are extrapolated to HIV/AIDS patients. HIV/AIDS, however, is known to cause morphological and ...
Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy
(Lippincott Wilkins & Williams, 2011)
Background: Tuberculosis-HIV (TB-HIV) coinfection remains an
important cause of mortality in antiretroviral therapy (ART)
programs. In a cohort of TB-HIV–coinfected patients starting
ART, we examined the incidence and ...
Prevalence of HIV/AIDS among breast cancer patients and the clinico-pathological presentation of breast cancer with HIV/AIDS in Mulago Hospital
(Makerere University, 2011-04)
Background: Breast cancer is the most common site-specific cancer accounting for 33% of all female cancers and is responsible for 20% of the cancer-related deaths in women.
Objective: To determine the prevalence of HIV ...